1. Home
  2. HALO vs BWA Comparison

HALO vs BWA Comparison

Compare HALO & BWA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • BWA
  • Stock Information
  • Founded
  • HALO 1998
  • BWA 1987
  • Country
  • HALO United States
  • BWA United States
  • Employees
  • HALO N/A
  • BWA N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • BWA Auto Parts:O.E.M.
  • Sector
  • HALO Health Care
  • BWA Consumer Discretionary
  • Exchange
  • HALO Nasdaq
  • BWA Nasdaq
  • Market Cap
  • HALO 7.6B
  • BWA 6.3B
  • IPO Year
  • HALO N/A
  • BWA 1993
  • Fundamental
  • Price
  • HALO $68.24
  • BWA $44.91
  • Analyst Decision
  • HALO Buy
  • BWA Buy
  • Analyst Count
  • HALO 11
  • BWA 13
  • Target Price
  • HALO $74.91
  • BWA $46.69
  • AVG Volume (30 Days)
  • HALO 2.2M
  • BWA 2.1M
  • Earning Date
  • HALO 11-03-2025
  • BWA 10-30-2025
  • Dividend Yield
  • HALO N/A
  • BWA 1.51%
  • EPS Growth
  • HALO 56.68
  • BWA N/A
  • EPS
  • HALO 4.74
  • BWA 0.61
  • Revenue
  • HALO $1,242,852,000.00
  • BWA $14,183,000,000.00
  • Revenue This Year
  • HALO $32.47
  • BWA $2.66
  • Revenue Next Year
  • HALO $24.31
  • BWA $2.78
  • P/E Ratio
  • HALO $14.41
  • BWA $73.87
  • Revenue Growth
  • HALO 31.19
  • BWA 0.10
  • 52 Week Low
  • HALO $42.01
  • BWA $24.40
  • 52 Week High
  • HALO $79.50
  • BWA $45.52
  • Technical
  • Relative Strength Index (RSI)
  • HALO 56.09
  • BWA 58.99
  • Support Level
  • HALO $67.40
  • BWA $40.90
  • Resistance Level
  • HALO $66.97
  • BWA $44.64
  • Average True Range (ATR)
  • HALO 2.04
  • BWA 1.16
  • MACD
  • HALO 0.51
  • BWA 0.19
  • Stochastic Oscillator
  • HALO 71.78
  • BWA 86.50

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About BWA BorgWarner Inc.

BorgWarner is a tier one supplier of turbo and thermal management technologies, drivetrain systems, powerdrive systems, and battery and charging systems mostly to automotive original equipment manufacturers. Its products aim to move a vehicle with as few electrons as possible, resulting in cleaner, cost-optimized, and more-efficient vehicles. Foundational products, the combustion vehicle business, contributes more than 80% to group revenue while BorgWarner transitions to becoming an electric vehicle-centric parts supplier (e-business). In 2023, 25% of the company's revenue was sourced from Volkswagen and Ford. Revenue is well diversified geographically, with approximately a third each generated in North America, Europe, and Asia.

Share on Social Networks: